Second primary lung malignancy following head and neck squamous cell carcinoma

ConclusionsPatients who undergo curative treatment of HNSCC are at high risk for developing SPLMs. Subsite ‐specific differences may help elucidate the degree of risk attributable to smoking, genetic susceptibility, human papillomavirus infection, or metastasis masquerading as an SPLM.Level of Evidence4Laryngoscope, 2018

Source: The Laryngoscope - November 22, 2018 Category: ENT & OMF Authors: Meghan M. Crippen, Jacob S. Brady, Lindsay A. Burke, Jean Anderson Eloy, Soly Baredes, Richard Chan Woo Park Tags: Head and Neck Source Type: research